ECONOMIC EVALUATION OF UMECLIDINIUM/VILANTEROL VERSUS UMECLIDINIUM OR SALMETEROL IN A UK COPD POPULATION AT LOW RISK OF EXACERBATIONS USING THE GALAXY MODEL

Shukla, S; Shah, D; Martin, A; Risebrough, NA; Kendall, R; Vogelmeier, CF; Boucot, I; Tombs, L; Bjermer, L; Jones, P; Kerwin, E; Compton, C; Maltais, F; Lipson, D; Ismaila, A

VALUE IN HEALTH, 2021; 24 (): S214

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索